BICLUSTER_ID : DNREG-220
PATHOGENS /4/ : escherichia coli,bifidobacterium bifidum,helicobacter pylori,burkholderia pseudomallei
TARGETS /9/ : UQCRC1, APEX1, TK1, PARP1, NDUFS8, MGST3, BCAT2, IDH1, DHCR7
Gene SetLeading Edge Genes
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPMGST3, H2AFX, CCNA2, ICT1, THAP11, GMNN, APEX1, MSH6, CDC20, WRB, PARP1, BCAT2, IDH1, PURA, DDX46, RNASEH2A, TK1, RPA1, ASPM
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UPKIF20A, PCK2, UCP2, NUDT3, H2AFX, NDUFS8, HMGB3, CENPF, UQCRC1, CDC20, PARP1, BCAT2, UBE2C, TMC6, KIF22, H2AFV, ARHGAP1, HMBS, DHCR7, EBP
LOPEZ MESOTELIOMA SURVIVAL TIME UP
NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
WILCOX PRESPONSE TO ROGESTERONE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION DN
NCI CENTROSOME MATURATION
BORCZUK MALIGNANT MESOTHELIOMA UP
MONTERO THYROID CANCER POOR SURVIVAL UP
KUMAMOTO RESPONSE TO NUTLIN 3A DN
MOOTHA HUMAN MITODB 6 2002
SHEPARD BMYB TARGETS
CORUM RC COMPLEX DURING G2/M-PHASE OF CELL CYCLE
STEIN ESRRA TARGETS
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
PRAMOONJAGO SOX4 TARGETS DN
CAFFAREL RESPONSE TO THC DN
REACTOME CENTROSOME MATURATION
KEGG OOCYTE MEIOSIS
KEGG PROPANOATE METABOLISM
NCI LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE ORGANIZATION FROM THE CENTROSOME
MOOTHA MITOCHONDRIA
STEIN ESRRA TARGETS UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
REACTOME G2 M TRANSITION
NCI LOSS OF NLP FROM MITOTIC CENTROSOMES
NCI RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
REACTOME CHOLESTEROL BIOSYNTHESIS
LY AGING MIDDLE DN
REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES
UDAYAKUMAR MED1 TARGETS UP
SHEPARD CRUSH AND BURN MUTANT DN
BIOCARTA AKAP95 PATHWAY
KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION
SESTO RESPONSE TO UV C6
JEON SMAD6 TARGETS DN
TANG SENESCENCE TP53 TARGETS DN
REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
CORUM RC COMPLEX DURING S-PHASE OF CELL CYCLE
KEGG PROGESTERONE MEDIATED OOCYTE MATURATION
LINDGREN BLADDER CANCER CLUSTER 1 DN
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
burkholderia pseudomalleibifidobacterium bifidumhelicobacter pylori kx2 mgephelicobacter pylori kx1 npgecescherichia coliGeneSet Name
-0.00532 -0.00072 -0.06916 -0.00733 -0.03431ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00050 -0.00023 -0.01305 -0.00205 -0.10364SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
-0.04587 -0.00051 -0.03218 -0.10536 -0.00060LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
-0.11862 -0.00385 -0.08620 -0.00148 -0.03360NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.02750 -0.00264 -0.05284 -0.02611 -0.01543WILCOX_PRESPONSE_TO_ROGESTERONE_UP
-0.12467 -0.00373 -0.00144 -0.00577 -0.15426DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
-0.11544 -0.08432 -0.11324 -0.00472 -0.00834NCI_CENTROSOME_MATURATION
-0.00016 -0.00139 -0.04124 -0.00038 -0.14538BORCZUK_MALIGNANT_MESOTHELIOMA_UP
-0.00042 -0.00022 -0.07595 -0.00349 -0.01652MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
-0.00073 -0.02902 -0.08113 -0.08108 -0.00055KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.00317 -0.00015 -0.04525 -0.00231 -0.18777MOOTHA_HUMAN_MITODB_6_2002
-0.00149 -0.00003 -0.00161 -0.19787 -0.06027SHEPARD_BMYB_TARGETS
-0.00378 -0.00028 -0.05125 -0.04330 -0.04060CORUM_RC_COMPLEX_DURING_G2/M-PHASE_OF_CELL_CYCLE
-0.12577 -0.00423 -0.01868 -0.00531 -0.16117STEIN_ESRRA_TARGETS
-0.00036 -0.00726 -0.02112 -0.02184 -0.00010THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
-0.00016 -0.00435 -0.00274 -0.02101 -0.00641PRAMOONJAGO_SOX4_TARGETS_DN
-0.00117 -0.00190 -0.06081 -0.00243 -0.16909CAFFAREL_RESPONSE_TO_THC_DN
-0.03691 -0.04334 -0.04721 -0.00297 -0.00057REACTOME_CENTROSOME_MATURATION
-0.04056 -0.00459 -0.01189 -0.01163 -0.06347KEGG_OOCYTE_MEIOSIS
-0.12766 -0.09374 -0.07154 -0.00444 -0.00176KEGG_PROPANOATE_METABOLISM
-0.11334 -0.08367 -0.10588 -0.00456 -0.00752NCI_LOSS_OF_PROTEINS_REQUIRED_FOR_INTERPHASE_MICROTUBULE_ORGANIZATION_FROM_THE_CENTROSOME
-0.00178 -0.00104 -0.05512 -0.00294 -0.16932MOOTHA_MITOCHONDRIA
-0.03686 -0.00248 -0.02890 -0.00298 -0.08961STEIN_ESRRA_TARGETS_UP
-0.01642 -0.02139 -0.08659 -0.03512 -0.05317RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.03193 -0.00061 -0.04505 -0.00240 -0.00142REACTOME_G2_M_TRANSITION
-0.10973 -0.08105 -0.10130 -0.00485 -0.00892NCI_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
-0.10845 -0.05676 -0.13285 -0.00296 -0.00253NCI_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
-0.12827 -0.06933 -0.00656 -0.00080 -0.01316REACTOME_CHOLESTEROL_BIOSYNTHESIS
-0.00004 -0.00146 -0.03223 -0.01642 -0.07770LY_AGING_MIDDLE_DN
-0.06128 -0.12803 -0.05496 -0.00303 -0.00468REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES
-0.00040 -0.00182 -0.08936 -0.01394 -0.07354UDAYAKUMAR_MED1_TARGETS_UP
-0.02242 -0.00019 -0.18475 -0.12253 -0.17532SHEPARD_CRUSH_AND_BURN_MUTANT_DN
-0.02186 -0.13191 -0.08874 -0.05628 -0.09967BIOCARTA_AKAP95_PATHWAY
-0.12647 -0.01075 -0.00209 -0.00054 -0.00397KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
-0.04011 -0.00481 -0.11512 -0.00278 -0.19455SESTO_RESPONSE_TO_UV_C6
-0.00740 -0.00006 -0.11485 -0.07564 -0.01358JEON_SMAD6_TARGETS_DN
-0.00127 -0.00022 -0.04893 -0.02427 -0.00033TANG_SENESCENCE_TP53_TARGETS_DN
-0.13439 -0.00352 -0.08274 -0.01616 -0.03446REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.03038 -0.00007 -0.17471 -0.03156 -0.07633CORUM_RC_COMPLEX_DURING_S-PHASE_OF_CELL_CYCLE
-0.09261 -0.02276 -0.14118 -0.00302 -0.07096KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
-0.00146 -0.00138 -0.13629 -0.01175 -0.14508LINDGREN_BLADDER_CANCER_CLUSTER_1_DN